Middle East and Africa Cell Therapy Instruments Market to Grow at a CAGR of 11.0% to reach US$ 899.62 Million from 2020 to 2027

The Middle East and Africa cell therapy instruments market was valued at US$ 398.23 Million in 2019 and is projected to reach US$ 899.62 Million by 2027; it is expected to grow at a CAGR of 11.0% during the forecast period.

Cell therapy includes the administration of somatic cell preparations by injecting or grafting into the patient’s body for the treatment of diseases or traumatic damages. Various instruments are used to carry out cell therapy to cure diabetes, neurological disorders, related injuries, some types of cancer, bones, and joints, and genetic disorders.

The increasing research and development in cell therapy have led to extraordinary therapeutic results in cell therapy instruments to improve the immune system and efficiently treat genetic disorders. Various market players provide several consumables such as reagents kits and enzymes, and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.

The use of equipment is essential for producing cell therapies such as NSC, PSC, MSC, T cells, and HSC. These cell therapy products are derived from animals or human cells and thus require safe conditions from contamination. Hence, the instruments used for cell therapies help in preventing contamination and allows scaling up the transplantation. For instance, companies such as Hitachi Chemical Advanced Therapeutics Solutions, Corning Incorporated, Thermo Fisher Scientific Inc., Miltenyi Biotec, LLC, Invetech, and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.

The Middle East and Africa countries are highly dependent on medical devices and pharmaceutical products and have faced several challenges for their requirements. Various US-based companies have their manufacturing units in the Middle East and African countries; hence initial phase of lockdown in multiple countries has affected the supply of instruments in this region. Therefore, many organizations are collaborating with others to overcome this pandemic by using cell therapies for the treatment of COVID 19.

Middle East and Africa Cell Therapy Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Middle East and Africa Cell Therapy Instruments Market

By Product

• Consumables
• Equipment

• Single-Use Equipment
• Cell Processing Equipment
• Other Equipment

• Systems and Software

By Cell Type

• Human Cells

• Differentiated Cells
• Stem Cells

• Animal Cells

By Process

• Cell Processing
• Process Monitoring and Quality Control
• Cell Preservation, Distribution, and Handling

By End User

• Research Institutes
• Life Science Research Companies
• Other End Users

By Geography

• Saudi Arabia
• South Africa
• UAE
• RoMEA

List of Companies

• STEMCELL Technologies Inc.
• Miltenyi Biotec
• General Electric Company
• THERMO FISHER SCIENTIFIC INC.
• MERCK KGaA

Middle East and Africa Cell Therapy Instruments Report Scope